SCHEMBL2497604

SCHEMBL2497604

COc1ccc(C)cc1C1(O)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
IDO1 P14902 2/20 0.46
KCNMA1 Q12791 2/20 0.46
KCNQ3 O43525 1/20 0.46
KCNQ2 O43526 1/20 0.46
KCNQ4 P56696 1/20 0.46
KCNQ5 Q9NR82 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
ALOX12 P18054 1/20 0.46
CBX7 O95931 2/20 0.44
CDYL Q9Y232 2/20 0.44
BRD4 O60885 3/20 0.43
MEN1 O00255 1/20 0.41
ADAMTS5 Q9UNA0 2/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495393 0.94 KMT2A (0.57) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2496356 0.90 KMT2A (0.51) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2497429 0.88 CBX7 (0.52) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2499035 0.86 KMT2A (0.53) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL5860255 0.86 KMT2A (0.50) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2496439 0.85 KMT2A (0.51) KMT2AKDM4EALDH1A1LMNAGAA
SCHEMBL2497668 0.85 KMT2A (0.51) KMT2AKDM4EALDH1A1LMNAGAA
SCHEMBL1464565 0.85 KMT2A (0.72) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2495110 0.84 KMT2A (0.48) KMT2AIDO1KCNMA1KCNQ3KCNQ2
SCHEMBL2495089 0.84 KMT2A (0.48) KMT2AIDO1KCNMA1KCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KMT2A 1662/4885IDO1 4/4885KCNMA1 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.